Get Premium to unlock powerful stock data
NAS:AUPH (Canada)  
Aurinia Pharmaceuticals Inc logo

Aurinia Pharmaceuticals Inc

$ 12.37 +0.98 (+8.6%) 08:08 PM EST
P/E:
At Loss
P/B:
3.92
Market Cap:
$ 1.75B
Enterprise V:
$ 1.20B
Volume:
3.87M
Avg Vol (2M):
2.91M
Also Trade In:
Volume:
3.87M
Market Cap $:
1.75B
PE Ratio:
At Loss
Avg Vol (2-Month):
2.91M
Enterprise Value $:
1.20B
PB Ratio:
3.92
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Aurinia Pharmaceuticals Inc
NAICS : 325412 SIC : 3741
4464 Markham Street, Suite 1203, Victoria, BC, CAN, V8Z 7X8
Description
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 48.86
Equity-to-Asset 0.88
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.38
Distress
Grey
Safe
Beneish M-Score 8.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.96
9-Day RSI 56.92
14-Day RSI 53.51
6-1 Month Momentum % -41.94
12-1 Month Momentum % -10.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.11
Quick Ratio 13.34
Cash Ratio 12.38
Days Inventory 5518.38
Days Sales Outstanding 56.4
Days Payable 850.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.3

Financials (Next Earnings Date:2022-08-05 Est.)

AUPH's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AUPH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 66.316
EPS (TTM) ($) -1.28
Beta 1.56
Volatility % 95.54
14-Day RSI 53.51
14-Day ATR ($) 0.880781
20-Day SMA ($) 10.986
12-1 Month Momentum % -10.6
52-Week Range ($) 8.86 - 33.9715
Shares Outstanding (Mil) 141.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aurinia Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More